Physician profile
Justin S Moon
NPI 1215019609
$1,358,294.29
in general payments reported to CMS, 2019-2025
100 companies · $233K in 2025
The $233K reported for 2025 was more than what 99% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141K · 2020: $179K · 2021: $238K · 2022: $258K · 2023: $133K · 2024: $177K · 2025: $233K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $249K · Consulting Fee: $80K · Honoraria: $69K · Travel and Lodging: $60K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $46K · Food and Beverage: $39K · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $248,920.00 |
| Consulting Fee | $79,945.00 |
| Honoraria | $68,633.00 |
| Travel and Lodging | $59,839.71 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $46,052.50 |
| Food and Beverage | $39,445.02 |
| Education | $101.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319,698.44 | 2019-2025 | |
| Lilly USA, LLC | $230,727.05 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Eisai INC. | $169,088.02 | 2019-2025 | |
| Amgen INC. | $161,493.71 | 2019-2025 | Aimovig, Uplizna |
| Allergan, INC. | $76,162.06 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $60,777.34 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Averitas Pharma INC. | $60,429.56 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $53,684.57 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $51,014.41 | 2021 | |
| Axsome Therapeutics, INC. | $37,447.39 | 2024-2025 | Symbravo, Sunosi |
| Pfizer INC. | $26,038.75 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $22,742.63 | 2022 | |
| Lundbeck LLC | $18,944.46 | 2019-2025 | Vyepti, Rexulti |
| Biogen, INC. | $14,939.12 | 2019-2025 | Vumerity, Tysabri, Spinraza |
| Eli Lilly and Company | $12,037.15 | 2021-2023 |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $6,365.39 | 2019-2025 | Hizentra, Privigen |
| Ipsen Biopharmaceuticals, INC | $5,335.48 | 2019-2025 | Dysport |
| Ucb, INC. | $3,116.14 | 2019-2025 | Nayzilam, Briviact, Fintepla |
| Novartis Pharmaceuticals Corporation | $2,055.02 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $1,801.89 | 2019-2025 | Ultomiris, Soliris |
| Emd Serono, INC. | $1,671.29 | 2019-2025 | Mavenclad |
| Livanova USA, INC. | $1,552.62 | 2019-2025 | Vns Therapy |
| Biodelivery Sciences International, INC. | $1,500.00 | 2022 | |
| Celgene Corporation | $1,454.43 | 2020-2025 | Zeposia |
| Sk Life Science, INC. | $1,245.59 | 2020-2025 | Xcopri |
| Banner Life Sciences, LLC | $1,182.79 | 2021-2024 | |
| Genentech USA, INC. | $1,076.23 | 2019-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Mdd US Operations, LLC | $973.89 | 2019-2025 | Gocovri, Gocovri, Qelbree |
| Merz Pharmaceuticals, LLC | $962.85 | 2021-2025 | Xeomin |
| Genzyme Corporation | $886.66 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $826.60 | 2019-2025 | Ingrezza, Ongentys |
| Tg Therapeutics, INC. | $715.76 | 2023-2025 | |
| Neurelis, INC. | $638.27 | 2021-2025 | Valtoco |
| Argenx US, INC. | $591.61 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Impel Pharmaceuticals INC. | $573.20 | 2022-2023 | Trudhesa |
| Jazz Pharmaceuticals INC. | $547.87 | 2020-2025 | |
| Acadia Pharmaceuticals INC | $468.75 | 2019-2025 | Nuplazid |
| Sunovion Pharmaceuticals INC. | $405.06 | 2019-2022 | |
| Adamas Pharmaceuticals, INC. | $370.33 | 2019-2021 | |
| Grifols USA, LLC | $363.11 | 2020-2025 | Gamunex-C |
| Catalyst Pharmaceuticals, INC. | $346.13 | 2020-2025 | Firdapse |
| Scilex Pharmaceuticals INC. | $335.02 | 2023-2025 | Ztlido |
| Akcea Therapeutics, INC. | $334.25 | 2019-2021 | |
| Tanabe Pharma America, INC. | $321.29 | 2019-2025 | Radicava |
| Supernus Pharmaceuticals, INC. | $309.20 | 2019-2022 | |
| Zyla Life Sciences, INC. | $302.49 | 2019-2020 | |
| Abbott Laboratories | $263.21 | 2021-2025 | Infinity |
| Assertio Therapeutics, INC. | $197.71 | 2020 | |
| Mallinckrodt Enterprises LLC | $195.98 | 2019 | |
| Merz North America, INC. | $190.98 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $168.65 | 2019-2023 | |
| Acorda Therapeutics, INC | $163.98 | 2020-2023 | Inbrija |
| Tonix Medicines, INC. | $162.28 | 2025 | Zembrace Symtouch |
| Amneal Pharmaceuticals LLC | $147.93 | 2019-2023 | Rytary |
| Octapharma USA, INC. | $137.24 | 2022-2025 | Panzyga |
| Life Molecular Imaging Ltd | $131.48 | 2024-2025 | Neuraceq |
| Zap Surgical Systems, INC. | $126.24 | 2022 | |
| Avid Radiopharmaceuticals, INC. | $125.00 | 2024 | |
| Novo Nordisk INC | $124.98 | 2024 | |
| Bausch Health US, LLC | $122.24 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $119.21 | 2023-2024 | Rexulti, Nuedexta |
| Avanir Pharmaceuticals, INC. | $114.09 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $112.91 | 2021 | |
| Ge Healthcare | $110.07 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $105.78 | 2022 | |
| Mallinckrodt Hospital Products INC. | $102.60 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $99.03 | 2022-2024 | Amvuttra |
| Genentech, INC. | $97.40 | 2025 | Ocrevus |
| Janssen Pharmaceuticals, INC | $96.77 | 2020-2022 | |
| Sobi, INC | $81.58 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $78.85 | 2023-2024 | Quviviq |
| Vanda Pharmaceuticals INC. | $77.99 | 2025 | Ponvory |
| Cycle Pharmaceuticals INC | $76.88 | 2024-2025 | Tascenso Odt, Bafiertam |
| Sumitomo Pharma America, INC. | $72.92 | 2023 | Aptiom |
| Amylyx Pharmaceuticals, INC. | $60.70 | 2023 | Relyvrio |
| Kyowa Kirin, INC. | $59.30 | 2020-2021 | |
| Greenwich Biosciences, INC. | $50.30 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $44.10 | 2022-2023 | Evusheld |
| Takeda Pharmaceuticals U.S.A., INC. | $43.43 | 2023-2024 | Gammagard, Hyqvia |
| Almatica Pharma LLC | $41.41 | 2021-2022 | |
| Bio Products Laboratory USA, INC. | $40.04 | 2023 | Gammaplex, Coagadex |
| Portola Pharmaceuticals, LLC | $36.38 | 2020 | |
| Nevro Corp. | $33.87 | 2024 | Senza |
| Kedrion Biopharma, INC. | $33.03 | 2022-2024 | Albuked, Koate, Rhogam Ultra-Filtered Plus |
| Cala Health, INC. | $30.66 | 2025 | Cala Kiq |
| Insightec,INC | $30.23 | 2023 | Exablate |
| Medtronic, INC. | $29.62 | 2022 | |
| Boston Scientific Corporation | $29.07 | 2023 | Wavewriter Alpha Prime 16 |
| Janssen Biotech, INC. | $24.66 | 2025 | |
| Kedrion Biopharma INC. | $24.06 | 2021 | |
| Ani Pharmaceuticals, INC. | $22.57 | 2022 | |
| Avion Pharmaceuticals | $22.38 | 2023 | Dhivy |
| Invivyd INC | $19.58 | 2025 | Pemgarda |
| Harmony Biosciences LLC | $19.45 | 2022 | |
| Azurity Pharmaceuticals, INC. | $18.57 | 2024 | Horizant |
| Saol Therapeutics INC. | $18.33 | 2019 | |
| Promius Pharma LLC | $17.94 | 2019 | |
| Medtronic USA, INC. | $17.54 | 2019 | |
| Sandoz INC. | $15.53 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $15.01 | 2022 |
Drugs and devices associated with these payments
Leqembi $161KQulipta $90KUbrelvy $86KQutenza $60KBotox $48KSymbravo $37KZavzpret $24KKisunla $16KDysport $5,164Hizentra $4,291Nurtec Odt $3,069Privigen $1,935Emgality $1,216Vyepti $1,162Aimovig $749Panzyga $735Nayzilam $724Zeposia $724Briumvi $716Kesimpta $671Ingrezza $668Ultomiris $648Gocovri $629Briviact $619Valtoco $530Vumerity $465Vyvgart Hytrulo $451Epidiolex $451Soliris $436Vyalev $421Xeomin $386Trudhesa $384Tysabri $369Ocrevus $350Ztlido $335Rexulti $322Vyvgart $312Mavenclad $311Ocrevus Zunovo $289Nuplazid $265Bafiertam $249Fintepla $224Rystiggo $217Infinity $214Reyvow $213Amyvid $202Fycompa $195Gamunex-C $192Uplizna $184Zembrace Symtouch $181Duopa $180Paxlovid $172Comirnaty $171Ajovy $142Neuraceq $131Spinraza $131Aduhelm $114Radicava $114Enspryng $85.80Quviviq $78.85Ponvory $77.99Firdapse $76.92Tascenso Odt $76.88Amvuttra $73.46Aptiom $72.92Radicava Ors $65.81Relyvrio $60.70Skyclarys $56.08Austedo Xr $47.34Inbrija $46.33Gammaplex $40.04Coagadex $40.04Elyxyb - Celecoxib $37.08Vns Therapy $36.81Senza $33.87Cala Kiq $30.66Ongentys $30.60Exablate $30.23Wavewriter Alpha Prime 16 $29.07Aubagio $27.05Rytary $23.71Qelbree $23.44Dhivy $22.38Gammagard $22.07Hyqvia $21.36Evusheld $20.97Pemgarda $19.58Tosymra $18.91Horizant $18.57Nuedexta $17.75Rhogam Ultra-Filtered Plus $13.65Koate $13.65Gammaked $13.65Kedrab $13.65Albuked $13.65Journavx $13.62Octagam Immune Globulin (Human) $8.38Sunosi $4.92Xcopri $1.75
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.